Bioventus entered into a definitive agreement to divest its bone morphogenetic protein development program to a new Viscogliosi Brothers company.
Biologics
Ortho Regenerative Technologies is an orthopedic biotechnology company developing novel therapeutic tissue repair devices for sports medicine surgeries.
Here are 23 study developments in spine and orthopedic biologics for 2018 so far:
AlloSource is the world's largest processor of cellular bone allografts.
Aziyo Biologics agreed to provide its viable bone matrix product ViBone to medical device company SurGenTec for use with the GraftGun universal graft delivery system.
Advertisement
Cerapedics completed a $22 million financing round to accelerate commercialization of its i-FACTOR Peptide Enhanced Bone Graft for degenerative disc disease.
The global spine biologics market is forecasted to grow at a 4.4 percent compound annual growth rate to exceed $2.6 billion by 2020, according to a Market Research Engine report.
Huntington, W. Va.-based Marshall Orthopaedics surgeon Chad Lavender, MD, is now performing anterior cruciate ligament repair procedures using a patient's bone marrow.
Adipose-derived autologous stem cell therapy may be used to successfully repair a meniscus injury, according to a study in the Journal of Medical Cases.
Here are five new biologic device launches or releases in 2018 so far: